A comparison of clinicopathological features and molecular markers in British and Nigerian women with breast cancer

Clinical Medicine: Oncology

Volumn 2, Issue , 2008, Pages 347-351

  Gukas, Isaac D ^a   Girling, Anne C ^b   Mandong, Barnabas M ^c   Prime, Wendy ^d   Jennings, Barbara A ^a   Leinster, Samuel J ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF JOS   (Nigeria)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Breast cancer; Immunocytochemistry; Molecular markers; Nigerian

Indexed keywords

EID: 84879838040     PISSN: None     EISSN: 11779314     Source Type: Journal    
DOI: 10.4137/cmo.s474     Document Type: Article

References (19)

1. Benson, J.R., Weaver, D.L., Mittra, I. et al. 2003. The TNM staging system and breast cancer. Lancet Oncol., 4:56-60.
2. Bosch, A.M., Kessels, A.G., Beets, G.L. et al. 2003. Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours. Eur. J. Radiol., 48:285-92.
3. Elledge, R.M., Clark, G.M., Chamness, G.C. et al. 1994. Tumour biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J. Natl. Cancer Inst., 86:705-12.
4. Gukas, I.D., Jennings, B.A., Mandong, B.M. et al. 2006. A comparison of the pattern of occurence of breast cancer in Nigeria and British women. The Breast, 15:90-5.
5. Gwyn, K., Bondy, M.L., Cohen, D.S. et al. 2004. Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer, 100:1595-604.
6. Harris, J.R., Lippman, M.E., Veronesi, U. et al. 1992. Breast cancer (1). N. Engl. J. Med., 327:319-28.
7. Ihekwaba, F.N. 1992. Breast cancer in Nigerian women. Br. J. Surg., 79:771-5.
8. Ihezue, C.H., Ugwu, B.T. and Nwana, E.J. 1994. Breast cancer in Highlanders. Nigerian Journal of Surgical Sciences, 4:1-4.
9. Key, T.J., Verkasalo, P.K. and Banks, E. 2001. Epidemiology of breast cancer. Lancet Oncol., 2:133-40.
10. Millis, R.R. 1980. Correlation of hormone receptors with pathological features in human breast cancer. Cancer, 46:2869-71.
11. Millis, R.R., Barnes, D.M., Lampejo, O.T. et al. 1998. Tumour grade does not change between primary and recurrent mammary carcinoma. Eur. J. Cancer, 34:548-53.
12. National Population Commission of Nigeria. 1998. 1991 Population Census of the Federal Republic of Nigeria: Analytical Report at the National Level., edn. Abuja, Nigeria: National Population Commission of Nigeria.
13. Okobia, M.N. and Osime, U. 2001. Clinicopathological study of carcinoma of the breast in Benin City. Afr J. Reprod. Health, 5:56-62.
14. Quinn, M. and Allen, E. 1995. Changes in Incidence and mortality of Breast Cancer in England and Wales Since Introduction of Screening. European Journal of Cancer, 311:1391-5
15. Royal College of Pathologists. Pathology Reporting of Breast Disease. NHSBSP Publication 58. 2005. 2006.
16. Shoker, B.S., Jarvis, C., Davies, M.P. et al. 2001. Immunodetectable cyclin D(1) is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br. J. Cancer, 84:1064-9.
17. Simpson, J.F. and Page, D.L. 1994. Status of breast cancer prognostication based on histopathologic data. Am. J. Clin. Pathol., 102:S3-8.
18. Stoner, M., Saville, B., Wormke, M. et al. 2002. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR.-75 breast cancer cells. Mol. Endocrinol., 16:2231-42.
19. U.K. National Statistics. Regional distribution of non-White population in U.K., April 2001. U.K. National Statistics. 2005.